Resumo
Definição
História e exame físico
Outros fatores diagnósticos
- uso de medicamentos
- irregularidade menstrual
- anemia
- molime pré-menstrual
- hirsutismo, acne, acantose nigricans
- Afecção clínica existente
Fatores de risco
- mulheres nos extremos da idade reprodutiva (logo após a puberdade e antes da menopausa)
- síndrome do ovário policístico
- endocrinopatias
- outros transtornos anovulatórios
- obesidade
Investigações diagnósticas
Investigações a serem consideradas
- perfil de coagulação
- nível de hormônio estimulante da tireoide (TSH) sérico
- ultrassonografia
- histeroscopia
- biópsia do endométrio
Algoritmo de tratamento
Colaboradores
Autores
Janesh Gupta, MSc, MD, FRCOG
Professor of Obstetrics and Gynaecology
Centre for Women's and Newborn Health
Institute of Metabolism and Systems Research
University of Birmingham
Birmingham Women’s and Children’s Hospital
Birmingham
UK
Declarações
JG is a clinical advisor for Femcare UK.
Akanksha Sood, MBBS, MS (OBGY), DNB, MRCOG, FACOG
Senior Clinical Fellow
Department of Reproductive Medicine
St. Mary’s Hospital
Manchester
UK
Declarações
AS declares that she has no competing interests.
Rohan Chodankar, MBBS, MD, MRCOG
ST6 Obstetrics and Gynaecology
Royal Infirmary of Edinburgh
Scotland
UK
Declarações
RC is supported as a Clinical Research Fellow by Bayer AG; RC is an author of references cited in this topic.
Agradecimentos
Professor Gupta, Dr Sood, and Dr Chodankar would like to gratefully acknowledge Dr Mohamed Mitwally and Dr Intisar Elnahhas, the previous contributors to this topic.
Declarações
MM owns a patent on the use of aromatase inhibitors for endometrial thinning before hysteroscopic surgery. The patent is licensed to Meditrina Company. IE declares that she has no competing interests.
Revisores
Janet Albers, MD
Associate Professor
Department of Family and Community Medicine
Southern Illinois University School of Medicine
Springfield
IL
Declarações
JA is an author of a reference cited in this topic.
Sarina Schrager, MD, MS
Associate Professor (CHS)
Department of Family Medicine
University of Wisconsin
WI
Declarações
SS declares that she has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011 Apr;113(1):3-13. Resumo
National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. May 2021 [internet publication].Texto completo
American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Jul 2012 [internet publication].Texto completo
American College of Obstetricians and Gynecologists. ACOG committee opinion no. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Apr 2013 [internet publication].Texto completo
American College of Obstetricians and Gynecologists. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Jul 2013 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível aqui.
O uso deste conteúdo está sujeito ao nosso aviso legal